Hofseth Biocare ASA
OTC:HOFBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hofseth Biocare ASA
OTC:HOFBF
|
NO |
|
Lassonde Industries Inc
TSX:LAS.A
|
CA |
|
H
|
Heidelberg Pharma AG
F:HPHA
|
DE |
|
A
|
Akamai Technologies Inc
XHAM:AK3
|
US |
|
M
|
Middleby Corp
F:MBY
|
US |
|
E
|
EDP SA
F:EDP
|
PT |
|
B
|
Boeing Co
XHAN:BCO
|
US |
|
AerCap Holdings NV
NYSE:AER
|
IE |
|
Diagnos Inc
XTSX:ADK
|
CA |
|
V
|
Ventas Inc
F:VEN
|
US |
|
TIC Solutions Inc
NYSE:TIC
|
US |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
S
|
SK Hynix Inc
XMUN:HY9H
|
KR |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
SWB:GUV
|
HU |
|
B
|
Ballard Power Systems Inc
XMUN:PO0
|
CA |
|
Standard Foods Corp
TWSE:1227
|
TW |
|
P
|
Preferred Bank
F:1IU
|
US |
|
F
|
Ford Motor Co
XHAM:FMC1
|
US |
|
Zscaler Inc
LSE:0XVU
|
US |
|
G
|
Gamehaus Holdings Inc
NASDAQ:GMHS
|
CN |
|
J
|
JD Sports Fashion PLC
OTC:JDDSF
|
UK |
|
V
|
Vallourec SA
OTC:VLOWY
|
FR |
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
IN |
|
S
|
Southern Co
DUS:SOT
|
US |
Bankruptcy Probability
Hofseth Biocare ASA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hofseth Biocare ASA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NO |
|
Hofseth Biocare ASA
OSE:HBC
|
615.4m NOK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hofseth Biocare ASA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hofseth Biocare ASA has total debt of 217.1m NOK. This includes both short-term (0 NOK) and long-term (217.1m NOK) debt.
You can find a full breakdown on its Balance Sheet.